BRIEF-Gilead And Kite Announce Presentation Of Transformative Data In 1L Metastatic Triple-Negative Breast Cancer, Updated Results In Multiple Myeloma And Early Data From Novel Investigational CAR T-Cell Therapy Targeting Brain Cancer At 2025 ASCO And EHA

Reuters
05-16
BRIEF-Gilead And Kite Announce Presentation Of Transformative Data In 1L Metastatic Triple-Negative Breast Cancer, Updated Results In Multiple Myeloma And Early Data From Novel Investigational CAR T-Cell Therapy Targeting Brain Cancer At 2025 ASCO And EHA

May 15 (Reuters) - Gilead Sciences Inc GILD.O:

  • GILEAD AND KITE ANNOUNCE PRESENTATION OF TRANSFORMATIVE DATA IN 1L METASTATIC TRIPLE-NEGATIVE BREAST CANCER, UPDATED RESULTS IN MULTIPLE MYELOMA AND EARLY DATA FROM NOVEL INVESTIGATIONAL CAR T-CELL THERAPY TARGETING BRAIN CANCER AT 2025 ASCO AND EHA

Source text: ID:nBw8SXQW4a

Further company coverage: GILD.O

((Reuters.Briefs@thomsonreuters.com;))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10